The European Union has requested dispute consultations with Turkey regarding various requirements imposed by Turkey on the production, import and approval for reimbursement, pricing and licensing of pharmaceutical products. The request was circulated to WTO members on 10 April.
Today, the EU has brought two disputes in the World Trade Organisation (WTO) against India and Turkey, respectively targeting unlawful import duties on Information and Communication Technology (ICT) products and unlawful measures on pharmaceuticals.
In both cases, there are significant economic interests and important legal principles at stake for the EU. The total value of affected European exports is estimated to be more than €1 billion a year.
New rules easing access to the EU single market for fertilisers made from organic or recycled materials and setting limits for cadmium were green-lighted by Parliament on Wednesday.
The world’s largest economies, particularly the EU, China, the US, Mexico and Canada, are all projected to suffer economically from the re-emergence of economic protectionism, and a significant increase in trade tariffs. In the case of the EU, the bloc would experience a 1% contraction in GDP, a 0.3% lower rate of employment, and a 1.1% decrease in imports by 2030, compared to a ‘no new tariffs’ baseline scenario.
Inspections for two EU-wide enforcement projects are currently under way to identify hazardous chemicals in consumer products. One project focuses on treated articles and chemical mixtures for consumer and professional uses under the Biocidal Products Regulation. The other targets REACH and CLP obligations for imported products and is performed in cooperation with customs authorities.